课题基金 / 基金详情

Thrombopoietin (TPO) regulates HIF-la levels through generation of mitochondrial reactive oxygen species

Thrombopoietin (TPO) regulates HIF-la levels through generation of mitochondrial reactive oxygen species
血小板生成素 (TPO) 通过产生线粒体活性氧来调节 HIF-1α 水平
批准号:
17591005
负责人:
KIRITO Keita
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

KIRITO Keita的其他基金

相似基金

相关文献

中文摘要
翻译
缺氧诱导因子(Hypoxia inducible factor, HIF)-1是调节细胞对缺氧适应的主要转录调控因子。此外,HIF-1对造血干细胞(hsc)的发育也至关重要。在先前的研究中,我们发现血小板生成素(TPO)是一种重要的、非冗余的细胞因子,用于维持和扩增HSC,通过增强HIF-1 α在常压条件下的稳定性,诱导原始造血细胞中HIF-1 α的表达。然而,这些作用的分子机制尚不完全清楚。最近,有报道称线粒体活性氧(ROS)在缺氧诱导的HIF-1 α稳定中起着至关重要的作用。因此,我们推测ROS也可能参与tpo诱导的HIF-1 α表达。在UT-7/TPO细胞和原代未成熟小鼠骨髓细胞中,ROS清除剂和线粒体电子传递抑制剂完全阻断TPO诱导的HIF-1 α。这些结果表明,TPO诱导HIF-1 a表达的方式与缺氧非常相似,并有助于解释该激素对HSC发育至关重要的基因的有利作用。
英文摘要
Hypoxia inducible factor (HIF)-1 is a master transcriptional regulator mediating the cellular adaptation to hypoxia. In addition, HIF-1 is also vital for the development of hematopoietic stem cells (HSCs). In a previous study we found that thrombopoietin (TPO), an important and non-redundant cytokine for HSC maintenance and expansion, induces HIF-1 α expression in primitive hematopoietic cells by enhancing the stability of HIF-1 α under normoxic conditions. However, the molecular mechanism of these effects are not yet fully understood. Recently, it was reported that mitochondrial reactive oxygen species (ROS) play a crucial role in hypoxia-induced stabilization of HIF-1 α. Thus, we speculated that ROS might also be involved in TPO-induced HIF-1 α expression. Both ROS scavengers and inhibitors of mitochondrial electron transport completely blocked HIF-1 α induction by TPO in UT-7/TPO cells and in primary immature mouse bone marrow cells. These results indicate that TPO induces HIF-1 a expression in a manner very similar to that of hypoxia, and helps to explain the favorable effects of the hormone on genes vital for HSC development.
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
RUNX1 suppression induces megakaryocytic differentiation of UT- 7/GM cells
RUNX1抑制诱导UT-7/GM细胞巨核细胞分化
DOI: --
发表时间: 2006
期刊: Biochem Biophys Res Commun 345
影响因子: --
作者: [Nagai R, Matsuura E, Hoshika Y, Nakata E, Nagura H, Watanabe A, Komatsu N, Okada Y, Doi T.]
通讯作者: Doi T.
DOI: 10.1038/sj.leu.2404593
发表时间: 2007-05-01
期刊: LEUKEMIA
影响因子: 11.4
作者: [Furukawa, Y., Vu, H. A., Kano, Y.]
通讯作者: Kano, Y.
DOI: 10.1182/blood-2004-08-3109
发表时间: 2005-05-15
期刊: BLOOD
影响因子: 20.3
作者: [Kanaji, S, Kanaji, T, Kunicki, TJ]
通讯作者: Kunicki, TJ
Transcriptional Regulation of Megakaryopoiesis : "TPO signaling andnuclear factors"
巨核细胞生成的转录调控:“TPO 信号传导和核因子”
DOI: --
发表时间: 2006
期刊: Current Opinion in Hematology In press
影响因子: --
作者: [Kirito, K]
通讯作者: K
共 17 条
    Enhanced ER stress response in MPN cells involved in development of myelofibrosis through secretion of GRP78
    • 批准号:
      18K08319
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2018
    • 负责人:
      KIRITO Keita
    • 依托单位:
    Role of glucose metabolism in development of myelofibrosis
    • 批准号:
      15K09470
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2015
    • 负责人:
      KIRITO Keita
    • 依托单位:
    Hypoxia modulate epigenomic response in MPN cells
    • 批准号:
      24591386
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.49万
    • 财政年份:
      2012
    • 负责人:
      KIRITO Keita
    • 依托单位:
    Hypoxia attenuates growth of MPN cells through suppression of SHP-2 expression and subsequent inhibition of JAK2V617F activity
    • 批准号:
      21591197
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2009
    • 负责人:
      KIRITO Keita
    • 依托单位:
    国内基金
    海外基金
    降脂消斑片通过HIF-1α/PKM2信号通路介导的能量代谢重编程抑制巨噬细胞铁死亡治疗动脉粥样硬化的作用机制
    HIF-1α-FtL信号轴通过调控神经元铁稳态抑制NLRP3炎性小体活化在脑缺血再灌注损伤中的作用与机制研究
    • 批准号:
      JCZRLH202600706
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    基于HIF-1α乳酸化修饰探讨桃红四物汤调控BMSCs-H型血管新生轴促进骨折愈合的分子机制研究
    • 批准号:
      2026JJ80362
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      周新
    • 依托单位:
    HIF-1α介导H3K18乳酸化调控石榴皮多酚改善痤疮皮脂代谢紊乱机制研究